Fairmount Funds Management LLC

Holdings History for Spyre Therapeutics, Inc. - Common Stock, par value $0.0001 per share (SYRE)

Symbol
SYRE on Nasdaq
Investment type
Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned
8,106,882 shares
Security Ownership %
10%
Shares, Excluding Options vs Price
Value, Excluding Options

Peter Evan Harwin ownership in Spyre Therapeutics, Inc. Common Stock, par value $0.0001 per share (SYRE)

17 Oct 2025 - Peter Evan Harwin has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 8,106,882 shares of Spyre Therapeutics, Inc. Common Stock, par value $0.0001 per share (SYRE). This represents 10% ownership of the company. This is the first filing by Fairmount Funds Management LLC disclosing ownership of Spyre Therapeutics, Inc. Common Stock, par value $0.0001 per share (SYRE).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.